The All.Can initiative is made possible with financial support from
Bristol-Myers Squibb (lead sponsor), Amgen and MSD (co-sponsors).

About Us

All.Can was set up to engage policymakers on the need to improve the efficiency of cancer care, focusing on better outcomes for patients. Our aim is to identify ways we can optimise the use of our resources in cancer care.

What we do

  • Lead and commission research to gather evidence on where system inefficiencies exist, and help identify ways to improve efficiency in cancer care
  • Develop concrete tools and platforms for stakeholders to work together to ensure cancer care decisions are focused on what matters most to patients, and resources are used as effectively as possible
  • Help to implement concrete policy actions based on these findings.

We are in the process of developing our work programme for 2017 and will have this available shortly.

How we work together

All.Can comprises leading representatives from patient organisations, policymakers, healthcare professionals, research and industry. All members contribute their time for free to the initiative, and all publications from the group reflect consensus of the members, who hold full editorial control.
The All.Can initiative is made possible with financial support from Bristol-Myers Squibb (lead sponsor), Amgen and MSD (co-sponsors).

Secretariat for the group is provided by the Health Policy Partnership, an independent consultancy who is paid for this role.

None of the content of All.Can discussions or activities is specific or biased to any specific treatment or therapy.

Why All.Can?

With the growing burden of cancer and financial pressures on our health care systems, there is an urgent need to improve the efficiency in cancer care.

Improving efficiency is not a question of linear cost-cutting – but of finding ways to allocate resources more efficiently to achieve better outcomes for patients.

This will require tough decisions, and thinking in terms of long-term investments rather than short-term policy fixes.

Watch our introduction video

View transcript

Why do we need to focus on improving the efficiency of cancer care?

“If things don’t change, we risk not being able to offer future generations the benefits of research advances in cancer, as governments will not be able, or willing, to pay for them.”1

Richard Sullivan, The Lancet Commission for Sustainable Cancer Care
Commission in High Income Countries (2011)
1. Sullivan R, Peppercorn J, Sikora K, et al. Delivering affordable cancer care in high-income countries.
The Lancet Oncology 2011;12(10):933–80.

All.Can members

Matti Aapro

Clinique Genolier

Vivek Muthu

Marivek Health Consulting

Kathy Oliver

The International Brain Tumour Alliance

Bettina Ryll

Melanoma Patient Network Europe

Francesco de Lorenzo

European Cancer Patients Coalition

Rainer Hess

GVG-Committee on Health Goals

Szymon Chrostowski

Polish Cancer Patient Coalition

Lieve Wierinck

European Parliament

Francesco Florindi

European Cancer Patients Coalition

Benjamin Gandouet

Oncopole Toulouse

Sabrina Hanna

Save Your Skin Foundation

Thomas Kelley

The International Consortium for Health Outcomes Measurement

Jason Arora

The International Consortium for Health Outcomes Measurement

Gilliosa Spurrier

Melanoma Patient Network Europe & Mélanome France

Thomas Szucs

University of Basel

Wendy Yared

Association of European Cancer Leagues

Denis Lacombe


Titta Rosvall-Puplett

Bristol Myers-Squibb

Isabel Roquete


Alexander Roediger



Health Policy Partnership


Towards sustainable cancer care:
Reducing inefficiencies, improving outcomes

A policy report from the All.Can initiative. January 2017

With the growing burden of cancer and pressures on limited healthcare budgets, past and current approaches to cancer care may not be sufficient for tomorrow. This report looks at improving efficiency
in cancer care as a means of securing better health outcomes for patients and making better use of available resources as a result. It examines where system inefficiencies exist, collects examples of good practice and derives lessons from them to help trigger policy action.

Download PDF

Download e-Book - Desktop version Download e-Book - Mobile version

Call to Action

1 Focus political will

“Inefficiencies in the system are a toxicity. There is no single formula for all countries that will deliver sustainable care, but we can agree on key principles, and make recommendations where efficiencies could be made to improve patient care.”

Lieve Wierinck
Member of the European Parliament

2 Place patient-relevant outcomes at the heart of everything we do

“As a patient, it is extremely frustrating and desperately worrying to be told that there is not enough money to fund the innovative cancer treatments you need when there is so much obvious waste within the healthcare system.”

Kathy Oliver
The International Brain Tumour Alliance

3 Invest in data

“We need to collect outcomes that matter to people in a standardised way… To start, we need to bring together communities of cancer providers from across the globe that sign up to this idea – so that together we can implement standardised measurement and enable its use by patients and professionals.”

Thomas Kelley
The International Consortium for Health Outcomes Measurement

4 Create greater accountability

“Too often, we don’t have the data available to really scrutinise the impact of given interventions or practices on patients across the entire cancer care pathway, and our efforts collapse into short-term cost-containment as a result.”

Vivek Muthu
Marivek Health Consulting

Watch our short "I.Can" video

News & Events

Greater efficiency in cancer care is achievable

The latest issue of the International Brain Tumour Alliance’s (IBTA) Brain Tumour magazine features an article about striving for greater efficiency in cancer care and the All.Can initiative, authored by Suzanne Wait (All.Can secretariat). The article sets out the current cancer care paradox: significant advances in cancer diagnostics and treatment on the one hand, and increasing cancer prevalence and financial pressures on healthcare systems on the other. Improving efficiency is the key to addressing this dilemma and the main driving force of the All.Can initiative. Although challenging, there is clear evidence that improving efficiency in cancer care is both possible and achievable, and the article provides some solid examples. You can read the full article in Brain Tumour magazine.

The IBTA’s Brain Tumour magazine is published annually and has a print circulation of approximately 13,000. Copies are sent to recipients in 113 countries for free, and it is widely distributed at international neuro-oncology and cancer conferences. The magazine includes interviews with eminent medical professionals from around the world; stories from brain tumour patients and carers; information on new approaches to treatment; and news from the international brain tumour community.

UK All.Can initiative launched: Transforming the Cycle in Cancer Care

With growing cancer prevalence and increasing financial pressures on the NHS, patients are facing poorer outcomes in the UK. In addition, the UK allocates much less of its health spending to cancer (3.8%) than the EU average (5%) and survival lags behind much of Europe. The UK All.Can initiative have produced a report ‘Transforming the Cycle in Cancer Care’ to address this challenge. The report was launched at parliament on March 22nd and sets out recommendations for transforming cancer care with little to no extra funding from the NHS. It shows improving efficiency is not just about cutting costs, but instead focusing resources on delivering what matters most to patients.

You can read the full report here or watch the animation.

Interview on All.Can in eCancer Journal

Dr Matti Aapro, All.Can member, spoke with ecancer at the 2017 St. Gallen International Breast Cancer Conference about the All.Can initiative. Watch the video here.

He discusses All.Can’s report which provides unique perspective on improving efficiency in cancer care to secure better outcomes for patients. He also outlines next steps for the initiative, as well as key points in treatment development and administration where waste can be reduced across Europe.

Contact Us

For any questions about All.Can, please contact Suzanne Wait,
the Health Policy Partnership (secretariat), at
Use the form below to get in touch.